However, treatments such as FSH antibodies, hormone replacement therapy, and FSHR blockade have been successfully applied in related conditions, such as osteoporosis, obesity, and hypercholesterolemia. Here, BRD2 is linked to obesity due to melanocortin 4 receptor deficiency.